Clinical Trials in Gilbert, Arizona

Find clinical trials in Gilbert, Arizona. Discover local research opportunities and treatment options in your area.

152 Active Trials Found in Gilbert

Showing 152 trials on this page

Page 1 of 8

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

NCT ID: NCT04267848

The ALCHEMIST trial is a clinical study looking at whether adding a drug called pembrolizumab, which is a type of immunotherapy, to standard chemotherapy can improve treatment outcomes for patients...

Recruiting

Phase: PHASE3 Conditions: Stage IIIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 +4 more

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

NCT ID: NCT05323253

This clinical trial is studying a new treatment called Alpha DaRT224 for patients with recurrent skin cancer known as cutaneous squamous cell carcinoma (SCC). The goal is to see how effective and s...

Recruiting

Phase: NA Conditions: Recurrent Squamous Cell Carcinoma

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

NCT ID: NCT06747949

This clinical trial is studying a medication called dazodalibep to see how safe it is for people with Sjögren's Syndrome when taken over a longer period of time. Sjögren's Syndrome is an autoimmune...

Recruiting

Phase: PHASE3 Conditions: Sjögren's Syndrome

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

NCT ID: NCT06858878

This clinical trial is exploring a new medication called maridebart cafraglutide to see how effective it is for adults with type 2 diabetes who are also overweight or have obesity. The main goal is...

Recruiting

Phase: PHASE3 Conditions: Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

NCT ID: NCT05317416

This clinical trial is studying a new treatment called elranatamab to see if it is more effective than a standard treatment called lenalidomide for patients with newly diagnosed multiple myeloma wh...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial

NCT ID: NCT05411081

The PAPMET2 trial is a research study that is exploring the effects of a new treatment combination for patients with advanced papillary kidney cancer, which is a type of kidney cancer that has spre...

Recruiting

Phase: PHASE2 Conditions: Stage IV Renal Cell Cancer AJCC v8, Metastatic Papillary Renal Cell Carcinoma

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT05843643

This clinical trial is studying the safety and effectiveness of a medication called upadacitinib for adults with moderate to severe systemic lupus erythematosus (SLE), a disease that causes inflamm...

Recruiting

Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

NCT ID: NCT06722157

This clinical trial is investigating a new treatment called BI 771716 for people aged 50 and older who have an advanced eye condition known as geographic atrophy, which is a type of age-related mac...

Recruiting

Phase: PHASE2 Conditions: Geographic Atrophy, Macular Degeneration, Age-related

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

NCT ID: NCT07000123

This clinical trial is studying a new medication called AZD0780, which is designed to lower levels of LDL cholesterol (often referred to as "bad" cholesterol) in the blood. The trial is for adults ...

Recruiting

Phase: PHASE3 Conditions: Cardiovascular Disease

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

NCT ID: NCT05894239

This clinical trial is studying a new treatment for patients with a specific type of advanced breast cancer known as HER2-positive metastatic breast cancer. The researchers want to find out if a dr...

Recruiting

Phase: PHASE3 Conditions: Metastatic Breast Cancer

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

NCT ID: NCT06497556

This clinical trial is studying a new treatment called divarasib for patients with advanced or metastatic non-small cell lung cancer (NSCLC) that has a specific mutation known as KRAS G12C. The goa...

Recruiting

Phase: PHASE3 Conditions: Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

NCT ID: NCT07106762

This clinical trial is studying a new treatment called Izalontamab Brengitecan for people with advanced urothelial cancer, a type of bladder cancer that has spread to other parts of the body. The t...

Not yet recruiting

Phase: PHASE2 Conditions: Urothelial Cancer

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

NCT ID: NCT04142437

This clinical trial is studying the safety and effectiveness of a drug called VITRAKVI (larotrectinib) for patients with TRK fusion cancer. TRK fusion cancer happens when a specific gene, called NT...

Recruiting

Conditions: Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

NCT ID: NCT05458297

This clinical trial is studying a new treatment called zilovertamab vedotin for patients with certain types of B-cell lymphomas, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (...

Recruiting

Phase: PHASE2 Conditions: Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma +2 more

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

NCT ID: NCT06312176

This clinical trial is studying a new treatment option for patients with a specific type of breast cancer called hormone receptor positive and HER2 negative (HR+/HER2-). The researchers want to see...

Recruiting

Phase: PHASE3 Conditions: Breast Neoplasms

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis

NCT ID: NCT06624228

This clinical trial is studying the effectiveness and safety of a medication called bimekizumab for adults with active psoriatic arthritis (PsA). PsA is a type of arthritis that can cause joint pai...

Recruiting

Phase: PHASE3 Conditions: Psoriatic Arthritis

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

NCT ID: NCT03142152

The EMPOWER Trial is studying a new treatment option for patients with heart failure who also have a condition called functional mitral regurgitation (FMR). FMR occurs when the heart's mitral valve...

Recruiting

Phase: NA Conditions: Heart Failure, Cardiovascular Diseases +4 more

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

NCT ID: NCT05155332

This clinical trial is studying a new medication called BI 1831169, which is being tested alone and in combination with another treatment known as a checkpoint inhibitor (anti-PD-1 antibody) in adu...

Recruiting

Phase: PHASE1 Conditions: Solid Tumors

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

NCT ID: NCT06119581

This clinical trial is investigating whether a new drug called LY3537982, combined with standard cancer treatments like immunotherapy and chemotherapy, is more effective for patients with advanced ...

Recruiting

Phase: PHASE3 Conditions: Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

NCT ID: NCT06380751

This clinical trial is studying a new combination treatment for patients with advanced breast cancer that is hormone receptor-positive and HER2-negative. The researchers want to see if the drug sar...

Recruiting

Phase: PHASE3 Conditions: Advanced Breast Cancer